Fund Holdings — Samsara BioCapital, LLC

Total Portfolio Value:
$477.80M
Total Bought:
$72.69M
Total Sold:
$34.06M
Net Transaction:
+$38.63M
Notable People:
Michael Philip Dybbs
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Cargo Therapeutics Inc4,121,6894,415,689+294,000$92.00M$72.51M15.17%-$19.49M
Mineralys Therapeutics, Inc.(MLYS)5,074,9165,074,9160$65.52M$59.38M12.43%-$6.14M
Scholar Rock Holding Corporation(SRRK)6,788,6096,788,6090$120.57M$56.55M11.84%-$64.02M
Neurogene Inc.(NGNE)1,267,7901,267,7900$64.53M$46.13M9.66%-$18.40M
Arcellx Inc
COMMON STOCK
453,641453,6410$31.55M$25.04M5.24%-$6.51M
Climb Bio, Inc.(CLYM)03,261,393+3,261,393$0$23.19M4.85%+$23.19M
Nkarta, Inc.(NKTX)3,768,0353,768,0350$40.73M$22.27M4.66%-$18.46M
LENZ Therapeutics, Inc.(LENZ)1,208,4731,208,4730$26.99M$20.89M4.37%-$6.09M
Avadel Pharmaceuticals Plc0967,527+967,527$0$13.60M2.85%+$13.60M
Jasper Therapeutics, Inc.(JSPR)525,000525,0000$15.41M$11.92M2.49%-$3.50M
Hillevax Inc799,274799,2740$13.29M$11.56M2.42%-$1.73M
ABIVAX Société AnonymeADS(ABVX)850,000850,0000$12.15M$11.24M2.35%-$918.0K
Acelyrin Inc2,523,0222,523,0220$17.03M$11.13M2.33%-$5.90M
Contineum Therapeutics, Inc.CL A(CTNM)0588,817+588,817$0$10.37M2.17%+$10.37M
Syros Pharmaceuticals Inc1,786,4271,786,4270$9.56M$9.22M1.93%-$339.4K
Zymeworks Inc.(ZYME)1,458,8751,000,000-458,875$15.35M$8.51M1.78%-$6.84M
Rhythm Pharmaceuticals, Inc.(RYTM)172,647172,6470$7.48M$7.09M1.48%-$391.9K
Inozyme Pharma Inc1,562,5001,562,5000$11.97M$6.97M1.46%-$5.00M
Sutro Biopharma, Inc.(STRO)1,675,5792,196,814+521,235$9.47M$6.44M1.35%-$3.03M
Gossamer Bio, Inc.(GOSS)6,130,2686,130,2680$7.23M$5.52M1.16%-$1.71M
Tango Therapeutics, Inc.(TNGX)630,000630,0000$5.00M$5.41M1.13%+$403.2K
Verona Pharma PlcADS347,500347,5000$5.59M$5.02M1.05%-$566.4K
Cypherpunk Technologies Inc.(CYPH)669,3032,442,352+1,773,049$1.78M$4.79M1.00%+$3.01M
Io Biotech Inc3,640,0153,640,0150$6.30M$4.26M0.89%-$2.04M
vTv Therapeutics Inc.CL A(VTVT)206,784206,7840$4.87M$3.65M0.76%-$1.21M
Prime Medicine, Inc.(PRME)540,304540,3040$3.78M$2.78M0.58%-$1.00M
Day One Biopharmaceuticals I
COM
196,425196,4250$3.24M$2.71M0.57%-$538.2K
Immatics N.V.SHS(IMTX)396,000198,000-198,000$4.16M$2.30M0.48%-$1.86M
Janux Therapeutics, Inc.(JANX)180,20745,052-135,155$6.78M$1.89M0.39%-$4.90M
Terns Pharmaceuticals Inc202,348202,3480$1.33M$1.38M0.29%+$50.6K
Igm Biosciences Inc154,664154,6640$1.49M$1.06M0.22%-$430.0K
Bolt Biotherapeutics Inc1,049,1531,049,1530$1.47M$786.9K0.16%-$681.9K
Lyra Therapeutics Inc2,780,2612,780,2610$17.29M$769.3K0.16%-$16.52M
Aclaris Therapeutics, Inc.(ACRS)696,171696,1710$863.3K$765.8K0.16%-$97.5K
Viracta Therapeutics Inc689,709689,7090$703.5K$375.0K0.08%-$328.5K
Allakos Inc172,089172,0890$216.8K$172.1K0.04%-$44.7K
Kronos Bio Inc78,13178,1310$101.6K$96.9K0.02%-$4.7K
Allovir Inc82,33682,3360$62.2K$59.6K0.01%-$2.6K
Nuvation Bio Inc.W EXP 07 07 202(NUVB)133,333133,3330$40.3K$21.3K0.00%-$19.0K
Surrozen, Inc.W EXP 08 01 203(SRZN)99,99999,9990$3.0K$1.7K0.00%-$1.4K
Adverum Biotechnologies Inc291,6660-291,666$4.12M$0—-$4.12M
Avadel Pharmaceuticals PlcADR967,5270-967,527$16.34M$0—-$16.34M
Page 1 of 1
Samsara BioCapital, LLC — 13F Holdings — Q2 2024 | TickerTrail